Annual Report filed on Form 20-F with SEC
Prana today announced it has filed its Annual Report on Form 20-F
Prana Alzheimer’s disease data features at world leading conference
Professor Rudolph Tanzi presents results from testing PBT2 in the “Alzheimer’s in a Dish Model” at the Alzheimer’s Association International Conference in Toronto, Canada.
Abstract from Movement Disorders Conference
Prana’s Huntington Disease trial analysis to feature at global movement disorder conference
Prana is pleased to announce that further analysis of the results of its REACH2HD trial will be featured at the 20th Annual International Movement Disorder Society Congress.
Prana receives $6.5 million R&D Tax Incentive Refund
Prana has today announced that is has received a A$6.5 million cash refund under the Australian Government’s R&D Tax Incentive Scheme.
Prana Presents at World Orphan Drug Congress
Prana presents unique drug platform at World Orphan Drug Congress
Prana Maintains NASDAQ Listing
Prana regains compliance with NASDAQ continued listing requirements and continues to work towards FDA submission
Prana Biotechnology AGM Presentation
Prana AGM Webcast Details
Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) will host a webcast of its Annual General Meeting on Friday, November 13, 2015, at 9.30am AEDT.